BMJ 2000;320:676-677 ( 11 March )

Papers

Using the Framingham model to predict heart disease in the United Kingdom: retrospective study

Editorial by Jackson

S Ramachandran, senior registrar, chemical pathology ^a,  J M French, research associate ^c,  M P J Vanderpump, consultant endocrinologist ^d,  P Croft, professor ^b,  R H Neary, consultant, chemical pathology ^a. 

^a Department of Clinical Biochemistry, North Staffordshire Hospital, Stoke on Trent ST4 7PA, ^b Department of Epidemiology, North Staffordshire Hospital, ^c Department of Statistics, University of Newcastle, Newcastle upon Tyne NE1 7RU, ^d Department of Endocrinology, Royal Free Hospital, London NW3 2QG

Correspondence to: R H Neary nearrh@netscape.net

The first 150 words of the full text of this article appear below.

Guidelines on the use of drugs to lower serum concentrations of lipids to prevent coronary heart disease target treatment to patients who have a high absolute risk of the disease. Although a patient's absolute risk of heart disease can be derived using risk tables¹for example, the Sheffield tablethese are based on the Framingham model which may not be applicable to the population in the United Kingdom.² We aimed to determine whether the Framingham model accurately predicts the risk of coronary heart disease among white men and women in the United Kingdom.

	Participants, methods, and results

A cross section of the population of Whickham, north east England, was enrolled in a study of ischaemic heart disease between 1972 and 1974 and followed up 20 years later.³ At baseline, data was collected on body mass index, family history of coronary heart disease, fasting glucose concentrations, and triglyceride concentrations. Standardised WHO questionnaires on chest pain were administered, and . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Framingham model for risk of heart disease fits a British population well
BMJ 2000 320: 0. [Full Text]

Guidelines on preventing cardiovascular disease in clinical practice

Rodney Jackson
BMJ 2000 320: 659-661. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Simmons, R. K., Coleman, R. L., Price, H. C., Holman, R. R., Khaw, K.-T., Wareham, N. J., Griffin, S. J. (2009). Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort. Diabetes Care 32: 708-713 [Abstract] [Full text]  
• Coleman, R. L., Stevens, R. J., Retnakaran, R., Holman, R. R. (2007). Framingham, SCORE, and DECODE Risk Equations Do Not Provide Reliable Cardiovascular Risk Estimates in Type 2 Diabetes. Diabetes Care 30: 1292-1293 [Full text]  
• Brindle, P, Beswick, A, Fahey, T, Ebrahim, S (2006). Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 92: 1752-1759 [Abstract] [Full text]  
• Reilly, B. M., Evans, A. T. (2006). Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions. ANN INTERN MED 144: 201-209 [Abstract] [Full text]  
• Rodriguez-Manas, L., Castro, M., Manzarbeitia, J. (2005). Review: Cardiovascular risk and diabetes in old people. British Journal of Diabetes & Vascular Disease 5: 7-11 [Abstract]  
• Hackam, D. G., Shumak, S. L. (2004). C-reactive protein for the prediction of cardiovascular risk: Ready for prime-time?. CMAJ 170: 1563-1565 [Full text]  
• Mattey, D L, Dawes, P T, Nixon, N B, Goh, L, Banks, M J, Kitas, G D (2004). Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease. Ann Rheum Dis 63: 420-425 [Abstract] [Full text]  
• Hense, H.-W. (2003). Risk factor scoring for coronary heart disease. BMJ 327: 1238-1239 [Full text]  
• Brindle, P., Emberson, J., Lampe, F., Walker, M., Whincup, P., Fahey, T., Ebrahim, S. (2003). Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 327: 1267- [Abstract] [Full text]  
• Hense, H.-W., Schulte, H., Lowel, H., Assmann, G., Keil, U. (2003). Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 24: 937-945 [Abstract] [Full text]  
• Marang-van de Mheen, P.J., ten Asbroek, A.H.A., Bonneux, L., Bonsel, G.J., Klazinga, N.S. (2002). Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands. Eur Heart J 23: 1922-1930 [Abstract]  
• May, M. (2002). Commentary: Improved coronary risk prediction using neural networks. Int J Epidemiol 31: 1262-1264 [Full text]  
• (2002). Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?. Heart 88: 222-228 [Abstract] [Full text]  
• Brindle, P., May, M. (2002). Commentary: The prediction of coronary heart disease risk in individuals-- an imprecise science. Int J Epidemiol 31: 822-824 [Full text]  
• Brindle, P., Fahey, T., Ebrahim, S. (2002). New score is needed to predict risk of coronary heart disease. BMJ 324: 1217-1217 [Full text]  
• Rabindranath, K S, Anderson, N R, Gama, R, Holland, M R (2002). Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation. Postgrad. Med. J. 78: 269-272 [Abstract] [Full text]  
• ROBSON, J., FEDER, G. (2001). Predicting and reducing cardiovascular risk. Heart 85: 487-488 [Full text]  
• Jones, A F, Walker, J, Jewkes, C, Game, F L, Bartlett, W A, Marshall, T, Bayly, G R (2001). Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Heart 85: 37-43 [Abstract] [Full text]  
• Jackson, R. (2000). Guidelines on preventing cardiovascular disease in clinical practice. BMJ 320: 659-661 [Full text]  

Online poll

Find out more here>> and here>>